Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma; Hepatocellular”

4,035 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,035 results

Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100
Not applicableStudy completedNCT03163186
What this trial is testing

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

Who this might be right for
Hepatic CarcinomaChemoembolizatonTransarterial Embolization
Medical University of South Carolina 55
Not applicableEnded earlyNCT03958669
What this trial is testing

Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC

Who this might be right for
Hepatocellular CarcinomaSorafenib
University Hospital Tuebingen 2
Large-scale testing (Phase 3)Study completedNCT00241020
What this trial is testing

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 270
Testing effectiveness (Phase 2)UnknownNCT03046979
What this trial is testing

Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)UnknownNCT01747642
What this trial is testing

Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma

Who this might be right for
Quality of Life
Clinical Research Organization, Dhaka, Bangladesh 60
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Not applicableLooking for participantsNCT06523179
What this trial is testing

Evaluation of Risk of hEpatocellular Carcinoma

Who this might be right for
NASHHCCGenetic Predisposition
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 500
Testing effectiveness (Phase 2)UnknownNCT01429961
What this trial is testing

Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Seoul National University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT02716766
What this trial is testing

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, HepatocellularSecondary
The University of Hong Kong 46
Testing effectiveness (Phase 2)Study completedNCT00614913
What this trial is testing

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Loma Linda University 76
Not applicableStudy completedNCT05640960
What this trial is testing

Undifferentiated Embryonal Sarcoma of the Liver: Evaluation of the Relapse Profile According to the Therapies Administered

Who this might be right for
Hepatic Sarcoma
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05904886
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

Who this might be right for
Hepatocellular Carcinoma
Hoffmann-La Roche 687
Not applicableLooking for participantsNCT06794073
What this trial is testing

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Who this might be right for
Carcinoma, HepatocellularNeoplasms, Glandular and EpithelialAdenocarcinoma+2 more
Shanghai Zhongshan Hospital 17
Testing effectiveness (Phase 2)UnknownNCT04913480
What this trial is testing

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 37
Not applicableStudy completedNCT02774161
What this trial is testing

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Who this might be right for
CirrhosisEarly Hepatocellular CarcinomaFibrosis+2 more
Stanford University 45
Large-scale testing (Phase 3)Study completedNCT00692770
What this trial is testing

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,114
Testing effectiveness (Phase 2)Looking for participantsNCT05797805
What this trial is testing

Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Iterion Therapeutics 178
Large-scale testing (Phase 3)Ended earlyNCT01108705
What this trial is testing

Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 87
Testing effectiveness (Phase 2)Study completedNCT00844883
What this trial is testing

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatoma
Yale University 50
Next Page